InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the complete record of transactions filed by Woodworth Marshall H. Officer active across 2 companies, notably MetaVia Inc.. Aggregated, 5 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 1 March 2024. The latest transaction was disclosed on 23 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Woodworth Marshall H is a declarant associated with MetaVia Inc. and NeuroBo Pharmaceuticals, Inc., where he is Chief Financial Officer. Across 5 filings in total, the 5 sampled filings run from 2024-03-04 to 2026-01-27, with buys of EUR 8702 and sells of EUR 0, and the modal transaction nature is Attribution.